Date: 24 Jul 2009
Abnormal skin barrier in the etiopathogenesis of atopic dermatitis
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Prior studies revealed the key roles played by T-helper type 1 and type 2 (Th1/Th2) cell dysregulation, IgE production, mast cell hyperactivity, and dendritic cell signaling in the evolution of the chronic, pruritic, inflammatory dermatosis that characterizes atopic dermatitis (AD). Accordingly, current therapy has been largely directed toward ameliorating Th2-mediated inflammation and pruritus. This article reviews emerging evidence that the inflammation in AD results from inherited and acquired insults to the barrier, as well as the therapeutic implications of this new paradigm.
References and Recommended Reading
Seidenari S, Giusti G: Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol 1995, 75:429–433.PubMed
Elias PM, Feingold KR: Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications. Arch Dermatol 2001, 137:1079–1081.PubMed
Elias PM: Stratum corneum defensive functions: an integrated view. J Invest Dermatol 2005, 125:183–200.PubMed
Weidinger S, Baurecht H, Wagenpfeil S, et al.: Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk. J Allergy Clin Immunol 2008, 122:560–568.e4.PubMedCrossRef
Lynley AM, Dale BA: The characterization of human epidermal filaggrin. A histidine-rich, keratin filament-aggregating protein. Biochim Biophys Acta 1983, 744:28–35.PubMed
Scott IR, Harding CR, Barrett JG: Histidine-rich protein of the keratohyalin granules. Source of the free amino acids, urocanic acid and pyrrolidone carboxylic acid in the stratum corneum. Biochim Biophys Acta 1982, 719:110–117.PubMed
Abe T, Ohkido M, Yamamoto K: Studies on skin surface barrier functions: skin surface lipids and transepidermal water loss in atopic skin during childhood. J Dermatol 1978, 5:223–229.PubMed
Werner Y, Lindberg M: Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol 1985, 65:102–105.PubMed
Fartasch M, Diepgen TL: The barrier function in atopic dry skin. Disturbance of membrane-coating granule exocytosis and formation of epidermal lipids? Acta Derm Venereol Suppl (Stockh) 1992, 176:26–31.
Nylander-Lundqvist E, Back O, Egelrud T: IL-1 beta activation in human epidermis. J Immunol 1996, 157:1699–1704.PubMed
Garg A, Chren MM, Sands LP, et al.: Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch Dermatol 2001, 137:53–59.PubMed
Nomura I, Goleva E, Howell MD, et al.: Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003, 171:3262–3269.PubMed
Sugarman J, Parish LJ: A topical lipid-based barrier repair formulation (EpiCeram cream) is high-effective monotherapy for moderate-to-severe pediatric atopic dermatitis. Presented at the IID Meeting 2008. Kyoto, Japan; May 14–17, 2008.
- Abnormal skin barrier in the etiopathogenesis of atopic dermatitis
Current Allergy and Asthma Reports
Volume 9, Issue 4 , pp 265-272
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links
- Industry Sectors